Literature DB >> 25368398

Chronic hepatitis B and liver cancer risks among Asian immigrants in New York City: Results from a large, community-based screening, evaluation, and treatment program.

Henry J Pollack1, Simona C Kwon2, Su H Wang3, Laura C Wyatt2, Chau Trinh-Shevrin2.   

Abstract

BACKGROUND: Hepatitis B virus (HBV) infection, the predominant cause of hepatocellular carcinoma (HCC) worldwide, disproportionately affects Asian Americans. Limited data exist on the variability and characteristics of infection that determine disease progression risk within U.S. Asian ethnic subgroups.
METHODS: Retrospective analyses were conducted on a large, community-based HBV screening and treatment program in New York City (NYC). From 2004 to 2008, the program enrolled 7,272 Asian-born individuals. Determinants of HBV seroprevalence were calculated and risk factors for HCC progression were compared across Asian subgroups.
RESULTS: Among newly tested individuals, 13% were HBV positive. Seroprevalence varied significantly with age, gender, education, birthplace, and family history of infection. Chinese-born individuals, particularly from the Fujian province, had the highest seroprevalence (23.2% and 33.1%, respectively). Clinical and virologic characteristics placed HBV-infected individuals at significant risk for HCC. Significant differences in HCC risk existed among Asian subgroups in bivariate analysis, including age, gender, HBV viral load, and HBeAg status. Differences in HBV genotype and family history of HCC may further HCC risk among subgroups.
CONCLUSIONS: Asian immigrants in NYC have a high prevalence of HBV infection and are at significant risk of disease progression and HCC. Although heterogeneity in HBV seroprevalence was found by Asian subgroups, HCC risk among infected individuals was primarily explained by age and gender differences. Country and province of birth, age, and gender may further explain seroprevalence differences. IMPACT: Findings provide estimates of HBV burden in Asian ethnic subgroups and identify high-risk groups to target for screening and treatment that can prevent HCC. ©2014 American Association for Cancer Research.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25368398      PMCID: PMC4373070          DOI: 10.1158/1055-9965.EPI-14-0491

Source DB:  PubMed          Journal:  Cancer Epidemiol Biomarkers Prev        ISSN: 1055-9965            Impact factor:   4.254


  56 in total

Review 1.  EASL Clinical Practice Guidelines: management of chronic hepatitis B.

Authors: 
Journal:  J Hepatol       Date:  2008-10-29       Impact factor: 25.083

2.  Racial disparities in hepatitis B infection in Ohio: screening and immunization are critical for early clinical management.

Authors:  Ranjita Misra; Karen Jiobu; Johnathan Zhang; Qihui Liu; Feng Li; Robert Kirkpatrick; Jason Ho
Journal:  J Investig Med       Date:  2013-10       Impact factor: 2.895

3.  The Asian American hepatitis B program: building a coalition to address hepatitis B health disparities.

Authors:  Chau Trinh-Shevrin; Henry J Pollack; Thomas Tsang; Jihyun Park; Mary Ruchel Ramos; Nadia Islam; Su Wang; Kay Chun; Shao-Chee Sim; Perry Pong; Mariano Jose Rey; Simona C Kwon
Journal:  Prog Community Health Partnersh       Date:  2011

4.  Molecular epidemiology of hepatitis B virus (HBV) genotypes and serotypes in patients with chronic HBV infection in Korea.

Authors:  Hong Kim; Young Mee Jee; Byung-Cheol Song; Jung Woo Shin; Soo Hyun Yang; Ho-Suk Mun; Hyun-Ju Kim; Eun-Ju Oh; Jung-Hwan Yoon; Yoon-Jun Kim; Hyo-Suk Lee; Eung-Soo Hwang; Chang-Yong Cha; Yoon-Hoh Kook; Bum-Joon Kim
Journal:  Intervirology       Date:  2006-11-24       Impact factor: 1.763

Review 5.  Prevention of hepatocellular carcinoma in hepatitis B virus infection.

Authors:  Seng Gee Lim; Rosmawati Mohammed; Man-Fung Yuen; Jia-Horng Kao
Journal:  J Gastroenterol Hepatol       Date:  2009-08       Impact factor: 4.029

Review 6.  Impact of therapy on the outcome of chronic hepatitis B.

Authors:  Yun-Fan Liaw
Journal:  Liver Int       Date:  2013-02       Impact factor: 5.828

7.  Urinary aflatoxin biomarkers and risk of hepatocellular carcinoma.

Authors:  R K Ross; J M Yuan; M C Yu; G N Wogan; G S Qian; J T Tu; J D Groopman; Y T Gao; B E Henderson
Journal:  Lancet       Date:  1992-04-18       Impact factor: 79.321

8.  Community-based hepatitis B screening programs in the United States in 2008.

Authors:  D B Rein; S B Lesesne; P J Leese; C M Weinbaum
Journal:  J Viral Hepat       Date:  2009-08-06       Impact factor: 3.728

9.  Prevalence, risk factors, and disease knowledge of chronic hepatitis B infection in Vietnamese Americans in California.

Authors:  Nghi B Ha; Huy N Trinh; Trang T Nguyen; Truong-Sinh Leduc; Christopher Bui; Nghiem B Ha; Carrie R Wong; Anh Thu Tran; Mindie H Nguyen
Journal:  J Cancer Educ       Date:  2013-06       Impact factor: 2.037

10.  Meta-analysis: The association of hepatitis B virus genotypes and hepatocellular carcinoma.

Authors:  G L-H Wong; H L-Y Chan; K K-L Yiu; J W-Y Lai; V K-K Chan; K K-C Cheung; E W-N Wong; V W-S Wong
Journal:  Aliment Pharmacol Ther       Date:  2013-01-10       Impact factor: 8.171

View more
  20 in total

1.  Cancer research in Asian American, Native Hawaiian, and Pacific Islander populations: accelerating cancer knowledge by acknowledging and leveraging heterogeneity.

Authors:  Scarlett Lin Gomez; Sally L Glaser; Pamela L Horn-Ross; Iona Cheng; Thu Quach; Christina A Clarke; Peggy Reynolds; Salma Shariff-Marco; Juan Yang; Marion M Lee; William A Satariano; Ann W Hsing
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2014-11       Impact factor: 4.254

2.  Cancer mortality rates among US and foreign-born individuals: United States 2005-2014.

Authors:  Benjamin D Hallowell; Meheret Endeshaw; Matthew T McKenna; Virginia Senkomago; Hilda Razzaghi; Mona Saraiya
Journal:  Prev Med       Date:  2019-06-18       Impact factor: 4.018

3.  Cluster-Randomized Trial to Increase Hepatitis B Testing among Koreans in Los Angeles.

Authors:  Roshan Bastani; Beth A Glenn; Annette E Maxwell; Angela M Jo; Alison K Herrmann; Catherine M Crespi; Weng K Wong; L Cindy Chang; Susan L Stewart; Tung T Nguyen; Moon S Chen; Victoria M Taylor
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2015-06-23       Impact factor: 4.254

4.  Disparities in mortality for chronic liver disease among Asian subpopulations in the United States from 2007 to 2016.

Authors:  Andrew A Li; Donghee Kim; Won Kim; Pratima Dibba; Katherine Wong; George Cholankeril; Ira M Jacobson; Zobair M Younossi; Aijaz Ahmed
Journal:  J Viral Hepat       Date:  2018-09-11       Impact factor: 3.728

5.  Opportunities and Challenges in Precision Medicine: Improving Cancer Prevention and Treatment for Asian Americans.

Authors:  Chau Trinh-Shevrin; Rachel Sacks; Jiyoung Ahn; Stella S Yi
Journal:  J Racial Ethn Health Disparities       Date:  2017-01-26

6.  Defining an integrative approach for health promotion and disease prevention: a population health equity framework.

Authors:  Chau Trinh-Shevrin; Nadia S Islam; Smiti Nadkarni; Rebecca Park; Simona C Kwon
Journal:  J Health Care Poor Underserved       Date:  2015-05

7.  Trends in liver cancer mortality in the United States: Dual burden among foreign- and US-born persons.

Authors:  Meheret Endeshaw; Benjamin D Hallowell; Hilda Razzaghi; Virginia Senkomago; Matthew T McKenna; Mona Saraiya
Journal:  Cancer       Date:  2018-11-27       Impact factor: 6.860

8.  Prevalence of Viral Hepatitis in Foreign-Born Populations in the Baltimore-Washington Metropolitan Area, 2009-2015.

Authors:  Hee-Soon Juon; Emmeline Ha; Frederic Kim; Amy Trang; Jane Pan; Janice Blanchard
Journal:  J Community Health       Date:  2019-04

Review 9.  Significance of hepatitis virus infection in the oncogenic initiation of hepatocellular carcinoma.

Authors:  Caecilia H C Sukowati; Korri E El-Khobar; Susan I Ie; Beatrice Anfuso; David H Muljono; Claudio Tiribelli
Journal:  World J Gastroenterol       Date:  2016-01-28       Impact factor: 5.742

10.  Cancer statistics for Asian Americans, Native Hawaiians, and Pacific Islanders, 2016: Converging incidence in males and females.

Authors:  Lindsey A Torre; Ann M Goding Sauer; Moon S Chen; Marjorie Kagawa-Singer; Ahmedin Jemal; Rebecca L Siegel
Journal:  CA Cancer J Clin       Date:  2016-01-14       Impact factor: 508.702

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.